Neuroscience
Alzheimer's Disease
100%
Apolipoprotein E
41%
Prospective Memory
36%
Amyloid Protein
33%
Basal Ganglia
29%
Placebo
26%
Parkinson's Disease
20%
Mindfulness
19%
Cholinergic
16%
Putamen
16%
Modafinil
16%
Repressor
16%
Cerebrovascular Disease
16%
Blood Plasma
16%
Apolipoprotein
16%
positron emission tomographic scan
14%
Enhancer Region
11%
Mild Cognitive Impairment
9%
Nasal Spray
9%
Neurodegenerative Disorder
8%
Cerebellum
8%
Parasympathomimetic Drug
7%
Cognitive Function
7%
Cerebrovascular Accident
6%
Frontal Lobe
5%
Psychology
Alzheimer's Disease
83%
Prospective Memory
50%
Basal Ganglion
33%
Mood
33%
Cognitive Function
22%
Mindfulness
21%
Psychological Intervention
16%
High-Risk Population
16%
Behavioral Intervention
16%
Working Memory
16%
Cognitive effects
16%
Negative Thinking
10%
Motor Skills
5%
Skill Acquisition
5%
Medicine and Dentistry
Alzheimer's Disease
50%
Amyloid Protein
33%
Pittsburgh Compound B
30%
Coronary Risk
20%
Brain Region
16%
Biological Marker
16%
Repressor Gene
16%
Genetic Risk
16%
Breathing
16%
Ethyl(phenyl)malonamide
16%
Combination Therapy
16%
High-Risk Population
16%
Personal Experience
16%
Cerebrovascular Disease
16%
Positron Emission Tomography
9%
Magnetic Resonance Imaging
6%
